Sanofi S.A. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other
companies in this sector in UNITED STATES :
Merck & Co. , Inc.
sales of $46.84 billion
of which 89%
was Merck Pharmaceutical),
of which 52%
was Pharmaceuticals), and
of which 78%
was Innovative Medicines).
During the year ended December of 2019, sales at
Sanofi S.A. were $42.06 billion.
a very small
increase of 0.1%
versus 2018, when the company's sales were $42.04 billion.
This was the third consecutive year of growth at Sanofi S.A..
The sales level in 2019 was fairly close to the level five years ago: in 2014, Sanofi S.A. had sales
of $45.04 billion.
Sales of Vaccines saw an increase
that was more than double the company's growth rate: sales were up
6.2% in 2019, from
$6.03 billion to $6.41 billion.
Not all segments of Sanofi S.A. experienced an increase in sales in 2019:
sales of Consumer Healthcare fell 4.6% to $5.24 billion.
Sanofi S.A. also experienced decreases in sales in
Pharmaceuticals (down 1.2% to $28.74 billion)